title: Prognostic value of TP53 codon 72 polymorphism in advanced gastric adenocarcinoma.
abstract: OBJECTIVE
  A common polymorphism of the tumor suppressor gene TP53 at codon 72 has been associated with human cancer susceptibility. The prognostic role of the polymorphism was assessed in 102 patients with advanced gastric adenocarcinoma.
  
  
  METHODS
  We followed up 102 consecutive Caucasian patients with advanced gastric adenocarcinoma for >5 years and determined the status of the TP53 codon 72 polymorphism in DNA samples extracted from archived gastric tissues.
  
  
  RESULTS
  The frequency of the arginine homozygous allele was positively correlated to patient age at baseline (P = 0.002). However, the age-related increase in the percentage of codon 72 arginine p53 was not correlated to the prognosis for gastric cancer patients. Multivariable analysis in patients who had surgery showed that baseline age may be inversely associated with patient survival (odds ratio, 1.1; 95% confidence interval, 1.0-1.2; P = 0.02). Furthermore, alcohol consumption may be associated with reduced survival (P = 0.06).
  
  
  CONCLUSIONS
  These findings indicate that codon 72 arginine p53 may not be associated with a prolonged survival in patients with advanced gastric adenocarcinoma, but further study is needed to assess whether this polymorphism is associated with a late onset or slow progress of early gastric adenocarcinoma.
authors.affiliation: Division of Surgery and Department of Histopathology, Bristol Royal Infirmary, University of Bristol, United Kingdom.
authors.forename: Zun-Wu
authors.initials: ZW
authors.lastname: Zhang
authors.forename: Nicola J
authors.initials: NJ
authors.lastname: Laurence
authors.forename: Andrew
authors.initials: A
authors.lastname: Hollowood
authors.forename: Paul
authors.initials: P
authors.lastname: Newcomb
authors.forename: Moganaden
authors.initials: M
authors.lastname: Moorghen
authors.forename: Jyoti
authors.initials: J
authors.lastname: Gupta
authors.forename: Roger
authors.initials: R
authors.lastname: Feakins
authors.forename: Michael J G
authors.initials: MJ
authors.lastname: Farthing
authors.forename: Derek
authors.initials: D
authors.lastname: Alderson
authors.forename: Jeff
authors.initials: J
authors.lastname: Holly
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics* / Q000473:pathology / Q000601:surgery; D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D001120:Arginine / Q000235:genetics; D003062:Codon / Q000235:genetics*; D004273:DNA, Neoplasm / Q000235:genetics; D005260:Female; D016158:Genes, p53; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic / Q000235:genetics*; D011379:Prognosis; D012307:Risk Factors; D013274:Stomach Neoplasms / Q000235:genetics* / Q000473:pathology / Q000601:surgery; D015996:Survival Rate
chemical_list: D003062:Codon; D004273:DNA, Neoplasm; D001120:Arginine